Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02715713
Other study ID # L16-059
Secondary ID
Status Withdrawn
Phase N/A
First received March 17, 2016
Last updated October 14, 2016
Start date March 2016
Est. completion date August 2016

Study information

Verified date October 2016
Source Texas Tech University Health Sciences Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The primary goal of this pilot study is to investigate the association between testosterone deficiency and the presence of abnormalities in the function of the autonomic nervous system. If such association exists, then we will investigate the effect of testosterone replacement therapy on correcting these abnormalities.


Description:

Read more »
Read more »

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
United States Texas Tech University Health Sciences Center Lubbock Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas Tech University Health Sciences Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with testosterone deficiency who will have abnormal autonomic function test (abnormal heart rate response to deep breathing, abnormal Valsalva ratio, and abnormal tilt table i.e. orthostatic hypotension). 24 months No
Secondary Number of patients with testosterone deficiency and abnormal autonomic function test who will have such abnormalities corrected if they receive testosterone replacement therapy as part of standard of care. 24 months No
See also
  Status Clinical Trial Phase
Completed NCT01446042 - Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Phase 3
Completed NCT02966652 - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism Phase 1
Completed NCT01228071 - Time to Eugonadal Range, Time to Steady State and Drying Time Phase 3
Completed NCT00858650 - Registry of Hypogonadism in Men N/A
Recruiting NCT05541172 - Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
Not yet recruiting NCT04704141 - Relationship of the Microenvironment and Male Fertility
Completed NCT01403116 - Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Phase 3
Completed NCT00911586 - Pharmacokinetic Study to Determine Time to Steady-state Phase 2
Completed NCT00924612 - Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Phase 2
Completed NCT01765179 - Safety and Efficacy Trial of Testosterone Undecanoate Phase 3
Completed NCT00475501 - 5-Alpha Reductase and Anabolic Effects of Testosterone Phase 2
Completed NCT04708249 - D-chiroinositol Administration in Hypogonadal Males N/A
Completed NCT02081300 - Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism Phase 3
Active, not recruiting NCT03721497 - Testosterone in Bariatric Patients Phase 4
Completed NCT01699178 - Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Phase 3